18 results match your criteria: "the SFI Research Centre for Medical Devices[Affiliation]"

Hydrogel three-dimensional (3D) printing has emerged as a highly valuable fabrication tool for applications ranging from electronics and biomedicine. While conventional hydrogels such as gelatin, alginate, and hyaluronic acid satisfy biocompatibility requirements, they distinctly lack reproducibility in terms of mechanical properties and 3D printability. Aiming to offer a high-performance alternative, here we present a range of amphiphilic star-shaped diblock copolypeptides of l-glutamate and l-leucine residues with different topologies.

View Article and Find Full Text PDF

Multiplex optical detection in live cells is challenging due to overlapping signals and poor signal-to-noise associated with some chemical reporters. To address this, the application of spectral phasor analysis to stimulated Raman scattering (SRS) microscopy for unmixing three bioorthogonal Raman probes within cells is reported. Triplex detection of a metallacarborane using the B-H stretch at 2480-2650 cm , together with a bis-alkyne and deuterated fatty acid can be achieved within the cell-silent region of the Raman spectrum.

View Article and Find Full Text PDF

Two-Photon Polymerization: Fundamentals, Materials, and Chemical Modification Strategies.

Adv Sci (Weinh)

March 2023

CÚRAM, the SFI Research Centre for Medical Devices, School of Chemical Sciences, Dublin City University, Glasnevin, Dublin 9, Ireland.

Two-photon polymerization (TPP) has become a premier state-of-the-art method for microscale fabrication of bespoke polymeric devices and surfaces. With applications ranging from the production of optical, drug delivery, tissue engineering, and microfluidic devices, TPP has grown immensely in the past two decades. Significantly, the field has expanded from standard acrylate- and epoxy-based photoresists to custom formulated monomers designed to change the hydrophilicity, surface chemistry, mechanical properties, and more of the resulting structures.

View Article and Find Full Text PDF

Background: Pregnancies affected by gestational diabetes mellitus (GDM) are associated with an increased risk of adverse maternal and foetal outcomes. Current treatments for GDM involve initial medical nutritional therapy (MNT) and exercise and pharmacotherapy in those with persistent hyperglycaemia. Insulin is considered first-line pharmacotherapy but is associated with hypoglycaemia, excessive gestational weight gain (GWG) and an increased caesarean delivery rate.

View Article and Find Full Text PDF

Another Step Toward Hepatitis C Elimination: An Economic Evaluation of an Irish National Birth Cohort Testing Program.

Value Health

December 2022

Health Information and Quality Authority, Dublin, Ireland; Department of Pharmacology and Therapeutics, Trinity College Dublin, Trinity Health Sciences, St James's Hospital, Dublin, Ireland.

Objectives: We aimed to evaluate the cost-effectiveness of offering once-off birth cohort testing for hepatitis C virus (HCV) to people in Ireland born between 1965 and 1985, the cohort with the highest reported prevalence of undiagnosed chronic HCV infection.

Methods: Systematic and opportunistic HCV birth cohort testing programs, implemented over a 4-year timeframe, were compared with the current practice of population risk-based testing only in a closed-cohort decision tree and Markov model hybrid over a lifetime time horizon. Outcomes were expressed in quality-adjusted life-years (QALYs).

View Article and Find Full Text PDF

Diagnostic concordance and discordance between angiography-based quantitative flow ratio and fractional flow reserve derived from computed tomography in complex coronary artery disease.

J Cardiovasc Comput Tomogr

July 2022

Discipline of Cardiology, Saolta Group, Galway University Hospital, Health Service Executive and CORRIB Core Lab, National University of Ireland Galway (NUIG), Galway, Ireland; CÚRAM, The SFI Research Centre for Medical Devices, Galway, Ireland.

Article Synopsis
  • The study examines the correlation between quantitative flow ratio (QFR) and fractional flow reserve (FFR) specifically in patients with complex coronary artery disease (CAD), focusing on those with three-vessel disease and/or left main CAD.
  • It is a post-hoc analysis from the SYNTAX III REVOLUTION trial, utilizing data from invasive and computed tomography angiography, assessing 469 vessels across 183 patients.
  • The findings revealed a strong correlation between QFR and FFR (R = 0.759; p < 0.001), with lesion location in the right coronary artery being a significant factor influencing the agreement between these two diagnostic methods.
View Article and Find Full Text PDF

Temporary Right-Ventricular Assist Devices: A Systematic Review.

J Clin Med

January 2022

Discipline of Cardiology, Saolta Group, Galway University Hospital, Health Service Executive and CORRIB Core Lab, National University of Ireland Galway (NUIG), H91 V4AY Galway, Ireland.

Acute right-sided heart failure (RHF) is a complex clinical syndrome, with a wide range of clinical presentations, associated with increased mortality and morbidity, but about which there is a scarcity of evidence-based literature. A temporary right-ventricular assist device (t-RVAD) is a potential treatment option for selected patients with severe right-ventricular dysfunction as a bridge-to-recovery or as a permanent solution. We sought to conduct a systematic review to determine the safety and efficacy of t-RVAD implantation.

View Article and Find Full Text PDF

Bicuspid aortic valve (BAV) is the most common valvular congenital anomaly and is apparent in nearly 50% of candidates for AV replacement. While transcatheter aortic valve implantation (TAVI) is a recommended treatment for patients with symptomatic severe aortic stenosis (AS) at all surgical risk levels, experience with TAVI in severe bicuspid AS is limited. TAVI in BAV is still a challenge due to its association with multiple and complex anatomical considerations.

View Article and Find Full Text PDF

Background And Objectives: Recognising the significant public health threat posed by hepatitis C, international targets have been established by the World Health Organization with the aim of eradicating the hepatitis C virus (HCV) by 2030. With the availability of safe and effective therapies, the greatest challenge to achieving elimination is the identification and treatment of those currently undiagnosed. This systematic review aimed to identify and appraise the international literature on the cost-effectiveness of birth cohort, universal, and age-based general population testing for identifying people with undiagnosed chronic HCV infection.

View Article and Find Full Text PDF

Hydrogels: 3D Drug Delivery Systems for Nanoparticles and Extracellular Vesicles.

Biomedicines

November 2021

Discipline of Surgery, Lambe Institute for Translational Research, National University of Ireland Galway, H91 V4AY Galway, Ireland.

Synthetic and naturally occurring nano-sized particles present versatile vehicles for the delivery of therapy in a range of clinical settings. Their small size and modifiable physicochemical properties support refinement of targeting capabilities, immune response, and therapeutic cargo, but rapid clearance from the body and limited efficacy remain a major challenge. This highlights the need for a local sustained delivery system for nanoparticles (NPs) and extracellular vesicles (EVs) at the target site that will ensure prolonged exposure, maximum efficacy and dose, and minimal toxicity.

View Article and Find Full Text PDF

The new-generation ACURATE 2 system was commercially released in September 2020. In this study, we sought to compare the aortic regurgitation (AR) severity of the ACURATE 2 versus the ACURATE transcatheter heart valve, using quantitative videodensitometric angiography (qAR). This is a retrospective, Corelab analysis of final post-transcatheter aortic valve implantation (TAVI) aortograms of patients treated with the ACURATE 2 and ACURATE systems.

View Article and Find Full Text PDF

Successful Coronary Artery Bypass Grafting Based Solely on Non-Invasive Coronary Computed Tomography Angiography.

Cardiovasc Revasc Med

July 2022

Centro Cardiologico Monzino, IRCCS, Milan, Italy; Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.

An 81-year-old female presented with chronic coronary disease (Canadian Cardiovascular Society angina severity grading III). The patient underwent coronary computed tomography angiography (CCTA) that revealed three-vessel coronary artery disease (3VD). This case illustrates that in a patient with 3VD, planning and execution of coronary artery bypass grafting (CABG) were successfully performed based solely on CCTA combined with fractional flow reserve derived from computed tomography angiography (FFR).

View Article and Find Full Text PDF

Ten-Year All-Cause Mortality Following Staged Percutaneous Revascularization in Patients With Complex Coronary Artery Disease.

Cardiovasc Revasc Med

May 2022

Department of Cardiology, National University of Ireland, Galway (NUIG) and CORRIB Corelab and Center for Research and Imaging, Galway, Ireland; CÚRAM, the SFI Research Centre for Medical Devices, Galway, Ireland.

Article Synopsis
  • The study investigates the effects of staged percutaneous coronary intervention (SPCI) on 10-year all-cause mortality in patients with complex coronary artery disease, specifically three-vessel disease (3VD) and left main disease (LM).
  • It was found that patients who underwent SPCI had significantly higher mortality rates over 10 years compared to those who either did not have SPCI or underwent coronary artery bypass grafting (CABG).
  • The conclusion suggests that CABG may be a better option than SPCI for patients who may require staged procedures, as SPCI was linked to increased mortality rates in both 3VD and LM patients.
View Article and Find Full Text PDF

Operator preference and determinants of size selection when additional intermediate-size aortic transcatheter heart valves are made available.

Int J Cardiol

September 2021

Department of Cardiology, National University of Ireland, Galway (NUIG) and CORRIB Corelab and Center for Research and Imaging, Galway, Ireland; CÚRAM, the SFI Research Centre for Medical Devices, Galway, Ireland.

Background: Appropriate size selection of transcatheter heart valves (THVs) is fundamental to reduce transcatheter aortic valve implantation (TAVI) related complications, particularly paravalvular aortic regurgitation, new permanent pacemaker implantation, and annular rupture. We sought to investigate the frequency of operator selection of intermediate-size balloon-expandable Myval THVs (Meril Life Sciences Pvt. Ltd.

View Article and Find Full Text PDF

Transient Permeation Enhancer® (TPE®) technology for oral delivery of octreotide: a technological evaluation.

Expert Opin Drug Deliv

October 2021

School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, St. Stephen's Green, Dublin 2, Ireland.

Article Synopsis
  • The FDA has approved oral formulations of peptides like semaglutide for diabetes and octreotide for acromegaly, showing that specific formulations can enable oral delivery.
  • An assessment of MYCAPSSA®, the oral octreotide formulation, highlights its competitive advantages over traditional depot injections and discusses the innovative Transient Permeation Enhancer (TPE®) technology used to improve intestinal absorption.
  • Despite oral octreotide having a much lower bioavailability compared to subcutaneous injections, its twice-daily convenience may appeal to acromegaly patients over less frequent injection methods.
View Article and Find Full Text PDF

Boron clusters as breast cancer therapeutics.

J Inorg Biochem

May 2021

School of Chemistry, Ryan Institute, National University of Ireland, Galway H91CF50, Ireland; CÚRAM, the SFI Research Centre for Medical Devices, National University of Ireland, Galway H91W2TY, Ireland. Electronic address:

Since the foundation of small molecule-based therapeutics over 100 years ago, their design has been dominated by organic based components. This has also been apparent in anti-cancer therapeutics in a broad range of strategies; from the older DNA chelating drugs, to the more recent molecular-targeted therapies. The main challenges facing current treatments; multidrug resistance and low therapeutic index, can potentially be alleviated by the incorporation of boron clusters.

View Article and Find Full Text PDF

design of additively manufacturable composite synthetic vascular conduits and grafts with tuneable compliance.

Biomater Sci

June 2021

School of Mechanical and Materials Engineering, UCD Centre for Biomedical Engineering, University College Dublin, Belfield, Ireland and CÚRAM, the SFI Research Centre for Medical Devices, Ireland.

Benchtop testing of endovascular medical devices under accurately simulated physiological conditions is a critical part of device evaluation prior to clinical assessment. Currently, glass, acrylic and silicone vascular models are predominantly used as anatomical simulator test beds for in vitro testing. However, most current models lack the ability to mimic the non-linear radial compliance of native vessels and are typically limited to being compliance-matched at a single mean pressure comparison point or not at all.

View Article and Find Full Text PDF